Freya Pharma Solutions Receives Early EMA Scientific Advice on its upcoming Phase 3 Clinical Trial to Confirm Efficacy of Lybrido in Women Suffering From FSIAD

/PRNewswire/ -- Freya Pharma Solutions, a late clinical stage pharmaceutical company focusing on the development of effective pharmaceutical therapies for...

Related Keywords

United States ,Netherlands ,Amsterdam ,Noord Holland ,American ,Marcel Wijma ,American Psychiatric Association ,European Medicines Agency ,Freya Pharma Solutions ,Lifespring Life Sciences Communication ,Committee For Medicinal Products Human Use ,Female Sexual ,Arousal Disorder ,Medicinal Products ,Human Use ,Chief Medical Officer ,Scientific Advisory Board ,Pharma Solutions ,Statistical Manual ,Mental Disorders ,Chief Executive Officer ,Spring Life Sciences Communication ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,Women ,